Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
E2F3 Transcription Factor | 33 | 2019 | 46 | 6.050 |
Why?
|
E2F Transcription Factors | 31 | 2019 | 48 | 4.170 |
Why?
|
Retinoblastoma Protein | 28 | 2022 | 75 | 3.550 |
Why?
|
E2F1 Transcription Factor | 27 | 2019 | 44 | 3.550 |
Why?
|
PTEN Phosphohydrolase | 17 | 2022 | 107 | 3.270 |
Why?
|
Repressor Proteins | 14 | 2019 | 182 | 3.130 |
Why?
|
Cell Cycle | 28 | 2022 | 312 | 3.080 |
Why?
|
E2F2 Transcription Factor | 20 | 2019 | 29 | 3.030 |
Why?
|
Cell Proliferation | 34 | 2021 | 1173 | 2.880 |
Why?
|
Cell Cycle Proteins | 29 | 2022 | 230 | 2.810 |
Why?
|
Mice | 114 | 2023 | 8472 | 2.540 |
Why?
|
Transcription Factors | 28 | 2019 | 753 | 2.310 |
Why?
|
Proto-Oncogene Proteins c-myc | 12 | 2021 | 90 | 2.100 |
Why?
|
Animals | 141 | 2023 | 20877 | 2.070 |
Why?
|
Signal Transduction | 37 | 2022 | 2688 | 1.690 |
Why?
|
Mice, Knockout | 37 | 2020 | 1692 | 1.610 |
Why?
|
Mammary Neoplasms, Experimental | 10 | 2018 | 114 | 1.530 |
Why?
|
Apoptosis | 26 | 2020 | 1640 | 1.520 |
Why?
|
E2F7 Transcription Factor | 9 | 2016 | 15 | 1.500 |
Why?
|
Embryonic Development | 9 | 2018 | 100 | 1.490 |
Why?
|
Placenta | 11 | 2019 | 101 | 1.480 |
Why?
|
Gene Expression Regulation | 21 | 2019 | 1293 | 1.470 |
Why?
|
Carcinoma, Hepatocellular | 3 | 2017 | 163 | 1.440 |
Why?
|
Liver Neoplasms | 4 | 2022 | 334 | 1.440 |
Why?
|
Epithelial Cells | 11 | 2019 | 431 | 1.430 |
Why?
|
Breast Neoplasms | 19 | 2022 | 1533 | 1.410 |
Why?
|
DNA-Binding Proteins | 24 | 2013 | 700 | 1.370 |
Why?
|
Pancreatic Neoplasms | 6 | 2023 | 332 | 1.350 |
Why?
|
Fibroblasts | 24 | 2023 | 902 | 1.320 |
Why?
|
Embryo, Mammalian | 12 | 2015 | 176 | 1.310 |
Why?
|
Cell Differentiation | 15 | 2019 | 1034 | 1.310 |
Why?
|
Trophoblasts | 8 | 2021 | 29 | 1.210 |
Why?
|
Gene Expression Regulation, Neoplastic | 20 | 2021 | 756 | 1.200 |
Why?
|
Cell Transformation, Neoplastic | 12 | 2023 | 235 | 1.130 |
Why?
|
Stromal Cells | 12 | 2022 | 113 | 1.130 |
Why?
|
Neoplasm Proteins | 9 | 2018 | 307 | 1.120 |
Why?
|
Chromatin Immunoprecipitation | 7 | 2017 | 52 | 1.100 |
Why?
|
S Phase | 11 | 2014 | 38 | 1.030 |
Why?
|
Tumor Suppressor Protein p53 | 12 | 2022 | 231 | 1.000 |
Why?
|
Carrier Proteins | 18 | 2014 | 597 | 0.950 |
Why?
|
Mammary Neoplasms, Animal | 6 | 2018 | 44 | 0.910 |
Why?
|
Pancreas | 3 | 2023 | 225 | 0.900 |
Why?
|
Endometrial Neoplasms | 2 | 2020 | 69 | 0.880 |
Why?
|
E2F4 Transcription Factor | 6 | 2019 | 9 | 0.880 |
Why?
|
Genome | 3 | 2018 | 54 | 0.880 |
Why?
|
Gene Deletion | 15 | 2018 | 235 | 0.880 |
Why?
|
Tumor Suppressor Proteins | 12 | 2010 | 194 | 0.870 |
Why?
|
Capsid Proteins | 12 | 2001 | 27 | 0.870 |
Why?
|
Mice, Transgenic | 25 | 2018 | 1032 | 0.850 |
Why?
|
Macrophages | 7 | 2017 | 647 | 0.840 |
Why?
|
Viral Proteins | 13 | 2001 | 149 | 0.840 |
Why?
|
Neoplasms | 7 | 2020 | 1660 | 0.810 |
Why?
|
Alleles | 6 | 2016 | 386 | 0.810 |
Why?
|
Cell Division | 17 | 2022 | 541 | 0.800 |
Why?
|
Promoter Regions, Genetic | 19 | 2019 | 614 | 0.790 |
Why?
|
Cyclin-Dependent Kinases | 12 | 2003 | 60 | 0.780 |
Why?
|
Cell Survival | 15 | 2021 | 901 | 0.770 |
Why?
|
Cornified Envelope Proline-Rich Proteins | 1 | 2020 | 4 | 0.770 |
Why?
|
Carcinoma | 4 | 2022 | 215 | 0.770 |
Why?
|
Phenylthiohydantoin | 1 | 2020 | 12 | 0.760 |
Why?
|
ras Proteins | 3 | 2022 | 102 | 0.760 |
Why?
|
Nitriles | 1 | 2020 | 68 | 0.750 |
Why?
|
Disease Models, Animal | 8 | 2022 | 2550 | 0.740 |
Why?
|
Intestine, Small | 3 | 2016 | 89 | 0.730 |
Why?
|
DNA | 6 | 2017 | 597 | 0.730 |
Why?
|
Transcriptome | 4 | 2019 | 164 | 0.720 |
Why?
|
Female | 59 | 2022 | 38015 | 0.700 |
Why?
|
Benzamides | 1 | 2020 | 156 | 0.700 |
Why?
|
Transcription, Genetic | 15 | 2019 | 562 | 0.690 |
Why?
|
Reoviridae | 9 | 2001 | 14 | 0.680 |
Why?
|
Mammary Glands, Animal | 6 | 2018 | 71 | 0.680 |
Why?
|
Origin Recognition Complex | 2 | 2018 | 5 | 0.670 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2020 | 332 | 0.670 |
Why?
|
Endoreduplication | 1 | 2018 | 3 | 0.660 |
Why?
|
Tumor Microenvironment | 9 | 2022 | 211 | 0.660 |
Why?
|
Cells, Cultured | 18 | 2019 | 2673 | 0.650 |
Why?
|
Genes, myc | 3 | 2016 | 26 | 0.650 |
Why?
|
CDC2-CDC28 Kinases | 6 | 2002 | 17 | 0.640 |
Why?
|
Chromatin | 4 | 2022 | 76 | 0.620 |
Why?
|
Cell Line, Tumor | 21 | 2022 | 1849 | 0.610 |
Why?
|
Genes, Neoplasm | 1 | 2017 | 18 | 0.600 |
Why?
|
Stem Cells | 5 | 2016 | 248 | 0.590 |
Why?
|
Gene Dosage | 1 | 2017 | 47 | 0.590 |
Why?
|
Carcinogenesis | 7 | 2023 | 124 | 0.590 |
Why?
|
MicroRNAs | 6 | 2020 | 447 | 0.590 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2017 | 68 | 0.590 |
Why?
|
Mice, Inbred C57BL | 20 | 2021 | 2790 | 0.590 |
Why?
|
Proto-Oncogene Protein c-ets-2 | 7 | 2016 | 49 | 0.580 |
Why?
|
Gene Regulatory Networks | 1 | 2017 | 94 | 0.580 |
Why?
|
Cell Nucleus | 6 | 2022 | 305 | 0.570 |
Why?
|
Humans | 85 | 2022 | 68525 | 0.550 |
Why?
|
Oligonucleotide Array Sequence Analysis | 10 | 2016 | 320 | 0.540 |
Why?
|
Cell Cycle Checkpoints | 1 | 2015 | 37 | 0.540 |
Why?
|
Pregnancy | 13 | 2021 | 2331 | 0.530 |
Why?
|
Genes, Retinoblastoma | 4 | 2016 | 4 | 0.520 |
Why?
|
Nuclear Proteins | 10 | 2018 | 271 | 0.520 |
Why?
|
Software | 2 | 2017 | 418 | 0.520 |
Why?
|
Mutation, Missense | 1 | 2015 | 112 | 0.510 |
Why?
|
Gene Knock-In Techniques | 2 | 2015 | 35 | 0.500 |
Why?
|
Gene Expression Profiling | 10 | 2019 | 498 | 0.500 |
Why?
|
Mesoderm | 4 | 2023 | 231 | 0.500 |
Why?
|
Receptor, ErbB-2 | 2 | 2018 | 128 | 0.490 |
Why?
|
Liver | 4 | 2022 | 1118 | 0.480 |
Why?
|
Placentation | 2 | 2013 | 6 | 0.460 |
Why?
|
Integrases | 3 | 2012 | 31 | 0.460 |
Why?
|
DNA Replication | 7 | 2003 | 167 | 0.460 |
Why?
|
Binding Sites | 5 | 2017 | 631 | 0.450 |
Why?
|
Cell Line | 23 | 2021 | 1752 | 0.450 |
Why?
|
Phenotype | 9 | 2017 | 946 | 0.450 |
Why?
|
Gene Expression Regulation, Developmental | 5 | 2017 | 328 | 0.440 |
Why?
|
Cloning, Molecular | 8 | 2005 | 357 | 0.440 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 8 | 2014 | 51 | 0.420 |
Why?
|
Gene Expression Regulation, Leukemic | 4 | 2018 | 29 | 0.420 |
Why?
|
Cell Lineage | 4 | 2017 | 146 | 0.410 |
Why?
|
Homeodomain Proteins | 4 | 2019 | 157 | 0.400 |
Why?
|
Cyclins | 5 | 2019 | 50 | 0.400 |
Why?
|
Protein Stability | 3 | 2019 | 89 | 0.390 |
Why?
|
Myeloid Progenitor Cells | 1 | 2010 | 9 | 0.390 |
Why?
|
Multigene Family | 4 | 2019 | 93 | 0.390 |
Why?
|
Phosphorylation | 12 | 2020 | 1199 | 0.390 |
Why?
|
Protein Binding | 10 | 2017 | 1027 | 0.380 |
Why?
|
Mutation | 11 | 2022 | 1213 | 0.380 |
Why?
|
Central Nervous System | 3 | 2009 | 107 | 0.380 |
Why?
|
T-Lymphocytes | 2 | 2007 | 595 | 0.380 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 5 | 2009 | 97 | 0.380 |
Why?
|
Caenorhabditis elegans Proteins | 2 | 2022 | 21 | 0.370 |
Why?
|
Hematopoietic Stem Cells | 8 | 2012 | 268 | 0.370 |
Why?
|
Hepatocytes | 3 | 2018 | 205 | 0.370 |
Why?
|
Proto-Oncogene Proteins c-akt | 5 | 2018 | 331 | 0.360 |
Why?
|
Embryonic Stem Cells | 1 | 2009 | 40 | 0.360 |
Why?
|
Cyclin E | 6 | 2003 | 19 | 0.360 |
Why?
|
Cyclin D1 | 3 | 2022 | 37 | 0.360 |
Why?
|
DNA Damage | 6 | 2019 | 190 | 0.360 |
Why?
|
Neoplasms, Glandular and Epithelial | 1 | 2009 | 22 | 0.360 |
Why?
|
Molecular Sequence Data | 17 | 2014 | 1446 | 0.350 |
Why?
|
Fetus | 4 | 2019 | 157 | 0.350 |
Why?
|
Carcinoma, Pancreatic Ductal | 2 | 2022 | 46 | 0.350 |
Why?
|
Embryo Loss | 6 | 2010 | 17 | 0.350 |
Why?
|
Lung Neoplasms | 4 | 2015 | 1172 | 0.350 |
Why?
|
Immunohistochemistry | 8 | 2019 | 1174 | 0.330 |
Why?
|
Neoplastic Stem Cells | 4 | 2018 | 84 | 0.330 |
Why?
|
Gene Expression | 8 | 2016 | 770 | 0.330 |
Why?
|
Neural Stem Cells | 2 | 2022 | 32 | 0.330 |
Why?
|
Growth | 1 | 2008 | 17 | 0.330 |
Why?
|
Pattern Recognition, Automated | 4 | 2011 | 70 | 0.330 |
Why?
|
Cyclin-Dependent Kinase 4 | 3 | 2022 | 34 | 0.330 |
Why?
|
Centrosome | 2 | 2010 | 6 | 0.330 |
Why?
|
Base Sequence | 15 | 2014 | 1015 | 0.320 |
Why?
|
Microscopy, Confocal | 5 | 2015 | 337 | 0.320 |
Why?
|
Flow Cytometry | 7 | 2019 | 489 | 0.320 |
Why?
|
Organ Specificity | 6 | 2017 | 167 | 0.320 |
Why?
|
Genotype | 4 | 2016 | 785 | 0.320 |
Why?
|
Enzyme Activation | 5 | 2018 | 791 | 0.320 |
Why?
|
Lymphoma | 2 | 2007 | 116 | 0.310 |
Why?
|
Diploidy | 1 | 2007 | 7 | 0.300 |
Why?
|
Cell Movement | 5 | 2018 | 630 | 0.300 |
Why?
|
Ovarian Neoplasms | 3 | 2021 | 267 | 0.300 |
Why?
|
G1 Phase | 7 | 2006 | 42 | 0.290 |
Why?
|
Male | 24 | 2021 | 37281 | 0.290 |
Why?
|
Receptors, Virus | 4 | 1996 | 20 | 0.290 |
Why?
|
Neovascularization, Physiologic | 4 | 2014 | 164 | 0.290 |
Why?
|
Image Interpretation, Computer-Assisted | 4 | 2011 | 237 | 0.290 |
Why?
|
Neoplasm Invasiveness | 4 | 2021 | 369 | 0.280 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 3 | 2018 | 63 | 0.270 |
Why?
|
STAT3 Transcription Factor | 2 | 2017 | 86 | 0.270 |
Why?
|
Genes, Tumor Suppressor | 5 | 2007 | 61 | 0.270 |
Why?
|
NF-kappa B | 2 | 2017 | 432 | 0.260 |
Why?
|
Disease Progression | 8 | 2019 | 1037 | 0.260 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2018 | 222 | 0.260 |
Why?
|
S Phase Cell Cycle Checkpoints | 2 | 2015 | 4 | 0.260 |
Why?
|
Image Processing, Computer-Assisted | 3 | 2022 | 689 | 0.250 |
Why?
|
Trans-Activators | 2 | 2017 | 237 | 0.250 |
Why?
|
Cancer-Associated Fibroblasts | 2 | 2022 | 9 | 0.250 |
Why?
|
RNA, Neoplasm | 3 | 2018 | 76 | 0.250 |
Why?
|
RNA, Messenger | 11 | 2021 | 1663 | 0.250 |
Why?
|
Gene Targeting | 4 | 2014 | 58 | 0.250 |
Why?
|
RNA-Binding Proteins | 2 | 2021 | 215 | 0.250 |
Why?
|
Transfection | 10 | 2017 | 782 | 0.240 |
Why?
|
Inflammation | 4 | 2022 | 1030 | 0.240 |
Why?
|
Transcriptional Activation | 4 | 2016 | 226 | 0.240 |
Why?
|
Mitosis | 5 | 2018 | 76 | 0.240 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 7 | 2012 | 710 | 0.240 |
Why?
|
Protein Phosphatase 2 | 2 | 2021 | 67 | 0.240 |
Why?
|
Mammals | 3 | 2022 | 47 | 0.240 |
Why?
|
Peptide Elongation Factor 2 | 1 | 2003 | 14 | 0.240 |
Why?
|
Cyclin-Dependent Kinase 6 | 2 | 2021 | 27 | 0.240 |
Why?
|
Tumor Burden | 2 | 2021 | 132 | 0.230 |
Why?
|
Protein Kinases | 2 | 2017 | 122 | 0.230 |
Why?
|
Killer Cells, Natural | 2 | 2015 | 94 | 0.230 |
Why?
|
Retinoblastoma-Binding Protein 1 | 13 | 2001 | 15 | 0.220 |
Why?
|
Adult Stem Cells | 1 | 2022 | 13 | 0.220 |
Why?
|
Blotting, Western | 8 | 2012 | 954 | 0.220 |
Why?
|
Gene Silencing | 4 | 2010 | 137 | 0.220 |
Why?
|
Protein Kinase Inhibitors | 3 | 2020 | 331 | 0.220 |
Why?
|
Endometrial Hyperplasia | 1 | 2022 | 4 | 0.210 |
Why?
|
Protein Folding | 4 | 2001 | 82 | 0.210 |
Why?
|
Eukaryotic Initiation Factor-4F | 1 | 2021 | 3 | 0.210 |
Why?
|
Oncogenes | 1 | 2022 | 71 | 0.210 |
Why?
|
Endothelial Cells | 4 | 2020 | 384 | 0.210 |
Why?
|
LDL-Receptor Related Proteins | 1 | 2021 | 4 | 0.210 |
Why?
|
Microtubule-Associated Proteins | 6 | 2004 | 114 | 0.210 |
Why?
|
Protein Processing, Post-Translational | 4 | 2019 | 284 | 0.210 |
Why?
|
Caenorhabditis elegans | 2 | 2022 | 38 | 0.210 |
Why?
|
Protein Biosynthesis | 6 | 2016 | 181 | 0.210 |
Why?
|
Phosphofructokinase-1, Type C | 1 | 2021 | 7 | 0.210 |
Why?
|
Antiphospholipid Syndrome | 1 | 2021 | 25 | 0.200 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2021 | 21 | 0.200 |
Why?
|
Receptors, CXCR4 | 1 | 2021 | 48 | 0.200 |
Why?
|
DNA Methylation | 5 | 2007 | 192 | 0.200 |
Why?
|
Proteins | 3 | 2000 | 473 | 0.200 |
Why?
|
Homeostasis | 1 | 2023 | 291 | 0.200 |
Why?
|
Leukemia, Promyelocytic, Acute | 2 | 2003 | 17 | 0.200 |
Why?
|
Non-alcoholic Fatty Liver Disease | 1 | 2022 | 87 | 0.190 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2001 | 74 | 0.190 |
Why?
|
Response Elements | 2 | 2015 | 29 | 0.190 |
Why?
|
Mammary Glands, Human | 2 | 2018 | 33 | 0.190 |
Why?
|
Models, Biological | 6 | 2014 | 981 | 0.190 |
Why?
|
Janus Kinase 2 | 2 | 2017 | 40 | 0.190 |
Why?
|
Cyclin D | 1 | 2020 | 12 | 0.190 |
Why?
|
Immunologic Surveillance | 2 | 2017 | 10 | 0.190 |
Why?
|
Adenosine Triphosphate | 3 | 2022 | 314 | 0.180 |
Why?
|
Metaplasia | 2 | 2016 | 27 | 0.180 |
Why?
|
Cell Communication | 2 | 2011 | 116 | 0.180 |
Why?
|
Algorithms | 6 | 2013 | 1194 | 0.180 |
Why?
|
SKP Cullin F-Box Protein Ligases | 1 | 2019 | 8 | 0.180 |
Why?
|
Microscopy | 2 | 2011 | 64 | 0.180 |
Why?
|
Chromosomal Instability | 1 | 2019 | 14 | 0.180 |
Why?
|
Pre-Eclampsia | 1 | 2021 | 202 | 0.170 |
Why?
|
p21-Activated Kinases | 1 | 2019 | 13 | 0.170 |
Why?
|
Biopsy | 3 | 2019 | 539 | 0.170 |
Why?
|
Sequence Analysis, DNA | 2 | 2017 | 208 | 0.170 |
Why?
|
Integrin beta1 | 1 | 2019 | 48 | 0.170 |
Why?
|
Morphogenesis | 3 | 2017 | 158 | 0.170 |
Why?
|
Cachexia | 1 | 2019 | 54 | 0.170 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 4 | 2022 | 78 | 0.170 |
Why?
|
Actin Cytoskeleton | 1 | 2019 | 37 | 0.170 |
Why?
|
Endometrium | 1 | 2018 | 31 | 0.170 |
Why?
|
Protein Kinase C-alpha | 1 | 2018 | 24 | 0.170 |
Why?
|
HEK293 Cells | 5 | 2019 | 326 | 0.160 |
Why?
|
RNA Interference | 2 | 2017 | 266 | 0.160 |
Why?
|
Radiation Tolerance | 1 | 2018 | 30 | 0.160 |
Why?
|
Tumor Cells, Cultured | 7 | 2021 | 852 | 0.160 |
Why?
|
Liver Regeneration | 1 | 2018 | 38 | 0.160 |
Why?
|
Chemokines | 2 | 2016 | 119 | 0.160 |
Why?
|
Adenosine Triphosphatases | 1 | 2018 | 83 | 0.160 |
Why?
|
Molecular Targeted Therapy | 1 | 2019 | 170 | 0.160 |
Why?
|
Estrogens | 1 | 2019 | 173 | 0.160 |
Why?
|
Janus Kinase 1 | 1 | 2017 | 3 | 0.160 |
Why?
|
Real-Time Polymerase Chain Reaction | 3 | 2015 | 209 | 0.160 |
Why?
|
Interleukin-11 | 1 | 2017 | 13 | 0.160 |
Why?
|
Enzyme Inhibitors | 6 | 2003 | 659 | 0.160 |
Why?
|
Chemokine CXCL12 | 1 | 2018 | 51 | 0.160 |
Why?
|
Hedgehog Proteins | 1 | 2018 | 38 | 0.160 |
Why?
|
Early Growth Response Protein 1 | 1 | 2018 | 42 | 0.160 |
Why?
|
DNA Nucleotidyltransferases | 1 | 2017 | 5 | 0.160 |
Why?
|
Intestinal Neoplasms | 1 | 2017 | 30 | 0.160 |
Why?
|
Cyclin-Dependent Kinase 2 | 6 | 2002 | 33 | 0.160 |
Why?
|
Phosphoproteins | 4 | 2001 | 202 | 0.160 |
Why?
|
Cell Adhesion Molecules | 1 | 2019 | 199 | 0.160 |
Why?
|
Interleukin-18 | 1 | 2017 | 16 | 0.160 |
Why?
|
Neoplasms, Experimental | 2 | 2017 | 118 | 0.160 |
Why?
|
Growth Differentiation Factor 15 | 1 | 2017 | 18 | 0.150 |
Why?
|
Transcription Factor DP1 | 9 | 2000 | 11 | 0.150 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2021 | 71 | 0.150 |
Why?
|
Cell Compartmentation | 2 | 2014 | 41 | 0.150 |
Why?
|
ras GTPase-Activating Proteins | 1 | 2017 | 6 | 0.150 |
Why?
|
Breast Feeding | 1 | 2019 | 159 | 0.150 |
Why?
|
Up-Regulation | 2 | 2018 | 682 | 0.150 |
Why?
|
Liposarcoma | 1 | 2017 | 13 | 0.150 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 1 | 2017 | 17 | 0.150 |
Why?
|
Stomach Neoplasms | 1 | 2017 | 64 | 0.150 |
Why?
|
Glucocorticoids | 1 | 2019 | 222 | 0.150 |
Why?
|
Saccharomyces cerevisiae Proteins | 1 | 1998 | 123 | 0.150 |
Why?
|
Interleukins | 1 | 2017 | 79 | 0.150 |
Why?
|
Erythropoiesis | 2 | 2008 | 24 | 0.150 |
Why?
|
Jagged-1 Protein | 1 | 2016 | 3 | 0.150 |
Why?
|
Adenocarcinoma | 2 | 2017 | 475 | 0.150 |
Why?
|
Vascular Endothelial Growth Factor A | 3 | 2012 | 219 | 0.150 |
Why?
|
Exosomes | 1 | 2017 | 44 | 0.150 |
Why?
|
Retinoblastoma Binding Proteins | 1 | 2016 | 2 | 0.150 |
Why?
|
Sex Characteristics | 1 | 2019 | 295 | 0.150 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 3 | 2003 | 174 | 0.150 |
Why?
|
Acinar Cells | 1 | 2016 | 8 | 0.150 |
Why?
|
Palatine Tonsil | 2 | 2017 | 8 | 0.150 |
Why?
|
Smoothened Receptor | 1 | 2016 | 10 | 0.150 |
Why?
|
Kaplan-Meier Estimate | 2 | 2015 | 536 | 0.150 |
Why?
|
Lymphocytes | 1 | 2017 | 228 | 0.140 |
Why?
|
Sequence Analysis, RNA | 1 | 2016 | 34 | 0.140 |
Why?
|
Chemotaxis, Leukocyte | 1 | 2016 | 48 | 0.140 |
Why?
|
Neoplasm Transplantation | 5 | 2019 | 160 | 0.140 |
Why?
|
Tretinoin | 2 | 2000 | 92 | 0.140 |
Why?
|
Protein Domains | 1 | 2016 | 74 | 0.140 |
Why?
|
Giant Cells | 2 | 2013 | 14 | 0.140 |
Why?
|
Pancreatic Ducts | 1 | 2016 | 76 | 0.140 |
Why?
|
Triple Negative Breast Neoplasms | 1 | 2016 | 41 | 0.140 |
Why?
|
Adenoviridae | 7 | 2004 | 295 | 0.140 |
Why?
|
CpG Islands | 2 | 2007 | 51 | 0.140 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2016 | 19 | 0.140 |
Why?
|
Hemorrhagic Disorders | 1 | 1995 | 7 | 0.140 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2016 | 89 | 0.140 |
Why?
|
HSP70 Heat-Shock Proteins | 1 | 1996 | 42 | 0.140 |
Why?
|
Mitochondrial Proteins | 1 | 2016 | 113 | 0.140 |
Why?
|
Cell Adhesion | 2 | 2015 | 324 | 0.140 |
Why?
|
Fibrinolysis | 1 | 1995 | 55 | 0.140 |
Why?
|
Protein Conformation | 4 | 1992 | 362 | 0.140 |
Why?
|
G2 Phase Cell Cycle Checkpoints | 1 | 2015 | 4 | 0.140 |
Why?
|
Oncogene Protein v-akt | 1 | 2015 | 25 | 0.140 |
Why?
|
G1 Phase Cell Cycle Checkpoints | 1 | 2015 | 12 | 0.140 |
Why?
|
Cysteine Endopeptidases | 1 | 1995 | 39 | 0.140 |
Why?
|
Mice, 129 Strain | 1 | 2015 | 44 | 0.130 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2015 | 23 | 0.130 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p15 | 5 | 2003 | 7 | 0.130 |
Why?
|
Macromolecular Substances | 6 | 1996 | 122 | 0.130 |
Why?
|
Blood Coagulation | 1 | 1995 | 123 | 0.130 |
Why?
|
Lymphocyte Subsets | 1 | 2015 | 16 | 0.130 |
Why?
|
Retina | 2 | 2009 | 252 | 0.130 |
Why?
|
3' Untranslated Regions | 2 | 2021 | 56 | 0.130 |
Why?
|
Gene Library | 2 | 2005 | 68 | 0.130 |
Why?
|
Protein-Tyrosine Kinases | 3 | 2019 | 195 | 0.130 |
Why?
|
Gene Knockout Techniques | 2 | 2014 | 61 | 0.130 |
Why?
|
Placental Circulation | 1 | 2014 | 1 | 0.130 |
Why?
|
Oncogene Proteins, Viral | 1 | 2014 | 21 | 0.120 |
Why?
|
Adenomatous Polyps | 1 | 2014 | 18 | 0.120 |
Why?
|
Piperidones | 1 | 2014 | 2 | 0.120 |
Why?
|
Body Patterning | 1 | 2014 | 44 | 0.120 |
Why?
|
STAT5 Transcription Factor | 1 | 2014 | 18 | 0.120 |
Why?
|
Hyperplasia | 2 | 2019 | 89 | 0.120 |
Why?
|
DNA Mutational Analysis | 3 | 2010 | 159 | 0.120 |
Why?
|
Immunity, Innate | 2 | 2017 | 156 | 0.120 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p27 | 5 | 2001 | 38 | 0.120 |
Why?
|
Aromatase | 2 | 2019 | 8 | 0.120 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2014 | 44 | 0.120 |
Why?
|
Intestines | 1 | 2014 | 114 | 0.120 |
Why?
|
Melanoma, Experimental | 1 | 2014 | 95 | 0.120 |
Why?
|
Capillaries | 1 | 2014 | 105 | 0.120 |
Why?
|
Precancerous Conditions | 2 | 2014 | 74 | 0.120 |
Why?
|
Protein Isoforms | 3 | 2013 | 246 | 0.120 |
Why?
|
Amino Acid Sequence | 5 | 2005 | 1082 | 0.120 |
Why?
|
ErbB Receptors | 3 | 2022 | 239 | 0.120 |
Why?
|
Chorionic Villi | 1 | 2013 | 5 | 0.120 |
Why?
|
Frizzled Receptors | 1 | 2013 | 8 | 0.120 |
Why?
|
SOXB1 Transcription Factors | 1 | 2013 | 20 | 0.110 |
Why?
|
Microscopy, Fluorescence | 2 | 2012 | 261 | 0.110 |
Why?
|
Hematopoiesis | 3 | 2006 | 108 | 0.110 |
Why?
|
Lymphocyte Activation | 1 | 2015 | 397 | 0.110 |
Why?
|
Prostatic Neoplasms | 1 | 2019 | 778 | 0.110 |
Why?
|
Antigens, Polyomavirus Transforming | 2 | 2014 | 15 | 0.110 |
Why?
|
Hypoxia-Inducible Factor 1 | 1 | 2012 | 16 | 0.110 |
Why?
|
Biomarkers, Tumor | 4 | 2021 | 508 | 0.110 |
Why?
|
Stress, Psychological | 1 | 2019 | 824 | 0.110 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2012 | 127 | 0.110 |
Why?
|
Genes, Lethal | 1 | 2012 | 16 | 0.110 |
Why?
|
Structure-Activity Relationship | 5 | 1996 | 420 | 0.110 |
Why?
|
Lymphopoiesis | 1 | 2012 | 16 | 0.110 |
Why?
|
Computational Biology | 1 | 2013 | 190 | 0.110 |
Why?
|
Skin Neoplasms | 1 | 2016 | 375 | 0.100 |
Why?
|
E2F5 Transcription Factor | 3 | 2009 | 4 | 0.100 |
Why?
|
Inactivation, Metabolic | 1 | 2011 | 28 | 0.100 |
Why?
|
Xenobiotics | 1 | 2011 | 17 | 0.100 |
Why?
|
S100 Proteins | 1 | 2011 | 42 | 0.100 |
Why?
|
Artificial Intelligence | 2 | 2011 | 159 | 0.100 |
Why?
|
Neoplasm Metastasis | 4 | 2018 | 306 | 0.100 |
Why?
|
Animals, Genetically Modified | 2 | 2012 | 63 | 0.100 |
Why?
|
Metabolic Networks and Pathways | 1 | 2011 | 65 | 0.100 |
Why?
|
T-Lymphocyte Subsets | 1 | 2012 | 126 | 0.100 |
Why?
|
Point Mutation | 2 | 2010 | 97 | 0.100 |
Why?
|
Cell Biology | 1 | 2011 | 4 | 0.100 |
Why?
|
Extracellular Matrix | 2 | 2017 | 493 | 0.100 |
Why?
|
Cytological Techniques | 1 | 2011 | 23 | 0.100 |
Why?
|
Retinoblastoma | 2 | 2015 | 26 | 0.100 |
Why?
|
DNA Breaks, Double-Stranded | 1 | 2010 | 24 | 0.100 |
Why?
|
NIH 3T3 Cells | 1 | 2010 | 65 | 0.100 |
Why?
|
CD11b Antigen | 1 | 2010 | 47 | 0.100 |
Why?
|
Time Factors | 4 | 2015 | 4655 | 0.100 |
Why?
|
Lung | 1 | 2015 | 849 | 0.090 |
Why?
|
Lens, Crystalline | 2 | 2016 | 39 | 0.090 |
Why?
|
Genes, ras | 1 | 2010 | 46 | 0.090 |
Why?
|
Models, Statistical | 1 | 2013 | 446 | 0.090 |
Why?
|
Mutant Proteins | 1 | 2010 | 45 | 0.090 |
Why?
|
Benzoxazines | 1 | 2009 | 20 | 0.090 |
Why?
|
Receptor, Cannabinoid, CB2 | 1 | 2009 | 27 | 0.090 |
Why?
|
Antigens, CD34 | 4 | 2007 | 75 | 0.090 |
Why?
|
Naphthalenes | 1 | 2009 | 47 | 0.090 |
Why?
|
Morpholines | 1 | 2009 | 79 | 0.090 |
Why?
|
Virion | 4 | 1994 | 31 | 0.090 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2009 | 150 | 0.090 |
Why?
|
Retinoblastoma-Like Protein p130 | 4 | 2007 | 7 | 0.090 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 2009 | 147 | 0.090 |
Why?
|
Receptor, Cannabinoid, CB1 | 1 | 2009 | 68 | 0.090 |
Why?
|
Peripheral Nervous System | 1 | 2008 | 12 | 0.090 |
Why?
|
Proto-Oncogene Protein c-ets-1 | 1 | 2009 | 65 | 0.090 |
Why?
|
Biomarkers | 3 | 2012 | 1593 | 0.080 |
Why?
|
Dimerization | 2 | 2008 | 99 | 0.080 |
Why?
|
Cannabinoids | 1 | 2009 | 90 | 0.080 |
Why?
|
Models, Animal | 2 | 2007 | 252 | 0.080 |
Why?
|
Neurogenesis | 2 | 2022 | 32 | 0.080 |
Why?
|
Multiple Endocrine Neoplasia | 1 | 2008 | 2 | 0.080 |
Why?
|
Cyclic AMP-Dependent Protein Kinase RIalpha Subunit | 1 | 2008 | 3 | 0.080 |
Why?
|
Subcellular Fractions | 1 | 2008 | 92 | 0.080 |
Why?
|
Heterografts | 2 | 2019 | 70 | 0.080 |
Why?
|
HeLa Cells | 2 | 2019 | 237 | 0.080 |
Why?
|
Neurons | 2 | 2007 | 881 | 0.080 |
Why?
|
Epigenesis, Genetic | 2 | 2007 | 163 | 0.080 |
Why?
|
Computer Graphics | 1 | 2008 | 37 | 0.080 |
Why?
|
Protein Structure, Tertiary | 2 | 2003 | 322 | 0.080 |
Why?
|
Eye | 1 | 2008 | 89 | 0.080 |
Why?
|
Receptors, Estrogen | 2 | 2019 | 142 | 0.080 |
Why?
|
Loss of Heterozygosity | 1 | 2008 | 25 | 0.080 |
Why?
|
Neoplasm Grading | 2 | 2018 | 110 | 0.080 |
Why?
|
Blast Crisis | 1 | 2007 | 7 | 0.080 |
Why?
|
Simian virus 40 | 1 | 2007 | 24 | 0.080 |
Why?
|
Placenta Diseases | 1 | 2007 | 5 | 0.080 |
Why?
|
Fusion Proteins, bcr-abl | 1 | 2007 | 37 | 0.080 |
Why?
|
Amacrine Cells | 1 | 2007 | 1 | 0.080 |
Why?
|
Lymphoma, T-Cell | 1 | 2007 | 19 | 0.080 |
Why?
|
Receptor, Platelet-Derived Growth Factor beta | 2 | 2020 | 20 | 0.080 |
Why?
|
Recombinant Fusion Proteins | 4 | 2002 | 376 | 0.080 |
Why?
|
Recombinant Proteins | 4 | 2002 | 742 | 0.080 |
Why?
|
Myeloid-Lymphoid Leukemia Protein | 1 | 2006 | 8 | 0.070 |
Why?
|
Tandem Repeat Sequences | 1 | 2006 | 13 | 0.070 |
Why?
|
Gastrointestinal Diseases | 1 | 2007 | 107 | 0.070 |
Why?
|
Gene Duplication | 1 | 2006 | 12 | 0.070 |
Why?
|
Prognosis | 3 | 2021 | 2093 | 0.070 |
Why?
|
Genetic Predisposition to Disease | 1 | 2010 | 785 | 0.070 |
Why?
|
DNA, Complementary | 2 | 2003 | 251 | 0.070 |
Why?
|
Mice, SCID | 2 | 2021 | 238 | 0.070 |
Why?
|
Neovascularization, Pathologic | 3 | 2014 | 183 | 0.070 |
Why?
|
Down-Regulation | 2 | 2011 | 447 | 0.070 |
Why?
|
Mice, Nude | 2 | 2021 | 294 | 0.070 |
Why?
|
E2F6 Transcription Factor | 1 | 2005 | 2 | 0.070 |
Why?
|
Collagen | 2 | 2019 | 636 | 0.060 |
Why?
|
Mice, Mutant Strains | 2 | 2015 | 166 | 0.060 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2004 | 43 | 0.060 |
Why?
|
Image Enhancement | 3 | 2011 | 143 | 0.060 |
Why?
|
Restriction Mapping | 5 | 2004 | 85 | 0.060 |
Why?
|
Retinal Rod Photoreceptor Cells | 1 | 2004 | 71 | 0.060 |
Why?
|
Dinucleoside Phosphates | 1 | 2003 | 2 | 0.060 |
Why?
|
3T3 Cells | 3 | 2016 | 124 | 0.060 |
Why?
|
Aneuploidy | 1 | 2003 | 21 | 0.060 |
Why?
|
Horses | 1 | 2003 | 20 | 0.060 |
Why?
|
Calcitonin | 1 | 2003 | 21 | 0.060 |
Why?
|
Helminth Proteins | 1 | 2022 | 2 | 0.060 |
Why?
|
Vulva | 1 | 2022 | 6 | 0.060 |
Why?
|
Calcitonin Gene-Related Peptide | 1 | 2003 | 46 | 0.060 |
Why?
|
Polymerase Chain Reaction | 3 | 2012 | 492 | 0.060 |
Why?
|
Genetic Vectors | 2 | 2009 | 311 | 0.050 |
Why?
|
ras-GRF1 | 1 | 2002 | 1 | 0.050 |
Why?
|
Genomic Imprinting | 1 | 2002 | 10 | 0.050 |
Why?
|
Connective Tissue | 1 | 2022 | 61 | 0.050 |
Why?
|
Epidermal Growth Factor | 1 | 2022 | 95 | 0.050 |
Why?
|
Rabbits | 3 | 2001 | 509 | 0.050 |
Why?
|
Diet, Western | 1 | 2022 | 17 | 0.050 |
Why?
|
Cell Growth Processes | 2 | 2014 | 40 | 0.050 |
Why?
|
Threonine | 1 | 2022 | 47 | 0.050 |
Why?
|
Fatty Acids | 1 | 2003 | 222 | 0.050 |
Why?
|
AU Rich Elements | 1 | 2021 | 1 | 0.050 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2002 | 27 | 0.050 |
Why?
|
Peptide Chain Initiation, Translational | 1 | 2021 | 3 | 0.050 |
Why?
|
Interleukin-15 | 2 | 2017 | 66 | 0.050 |
Why?
|
Leukemia, Myeloid | 1 | 2001 | 39 | 0.050 |
Why?
|
Karyopherins | 1 | 2021 | 11 | 0.050 |
Why?
|
Chromosomes, Human, Pair 8 | 1 | 2001 | 54 | 0.050 |
Why?
|
Megakaryocytes | 1 | 2001 | 18 | 0.050 |
Why?
|
B-Lymphocytes | 1 | 2003 | 329 | 0.050 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2021 | 55 | 0.050 |
Why?
|
Glycosylation | 1 | 2022 | 185 | 0.050 |
Why?
|
Myelodysplastic Syndromes | 1 | 2001 | 24 | 0.050 |
Why?
|
Antibodies, Antiphospholipid | 1 | 2021 | 29 | 0.050 |
Why?
|
Mammalian orthoreovirus 3 | 2 | 1991 | 3 | 0.050 |
Why?
|
RNA Stability | 1 | 2021 | 55 | 0.050 |
Why?
|
Ligands | 1 | 2022 | 317 | 0.050 |
Why?
|
Amifostine | 1 | 2001 | 3 | 0.050 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2021 | 57 | 0.050 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2021 | 100 | 0.050 |
Why?
|
Lymphocyte Count | 1 | 2001 | 53 | 0.050 |
Why?
|
Mice, Inbred NOD | 1 | 2021 | 138 | 0.050 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2001 | 22 | 0.050 |
Why?
|
DNA Fragmentation | 1 | 2001 | 85 | 0.050 |
Why?
|
Hodgkin Disease | 1 | 2001 | 27 | 0.050 |
Why?
|
Proto-Oncogenes | 1 | 2001 | 37 | 0.050 |
Why?
|
Adenovirus E2 Proteins | 1 | 2000 | 1 | 0.050 |
Why?
|
Gamma Rays | 2 | 2018 | 64 | 0.050 |
Why?
|
HSP90 Heat-Shock Proteins | 1 | 2001 | 46 | 0.050 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2021 | 91 | 0.050 |
Why?
|
Mass Spectrometry | 1 | 2022 | 284 | 0.050 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2014 | 304 | 0.050 |
Why?
|
DNA Repair | 1 | 2001 | 127 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2001 | 33 | 0.050 |
Why?
|
Transforming Growth Factor beta | 2 | 2001 | 384 | 0.050 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2004 | 300 | 0.050 |
Why?
|
Actins | 2 | 2014 | 249 | 0.050 |
Why?
|
Caspases | 1 | 2001 | 194 | 0.050 |
Why?
|
Disease Susceptibility | 2 | 2019 | 179 | 0.050 |
Why?
|
Hepatocyte Growth Factor | 1 | 2001 | 63 | 0.050 |
Why?
|
Sensitivity and Specificity | 3 | 2011 | 1753 | 0.050 |
Why?
|
Caspase 3 | 1 | 2001 | 233 | 0.050 |
Why?
|
Autocrine Communication | 1 | 2000 | 37 | 0.050 |
Why?
|
DNA, Neoplasm | 3 | 2007 | 95 | 0.050 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2022 | 265 | 0.050 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2021 | 214 | 0.050 |
Why?
|
Cell Death | 1 | 2001 | 329 | 0.050 |
Why?
|
Histones | 2 | 2013 | 111 | 0.050 |
Why?
|
Dendritic Cells | 2 | 2017 | 201 | 0.040 |
Why?
|
Cell-Free System | 2 | 1996 | 43 | 0.040 |
Why?
|
Leukemia | 1 | 2000 | 117 | 0.040 |
Why?
|
Genetic Fitness | 1 | 2019 | 8 | 0.040 |
Why?
|
Gene Ontology | 1 | 2019 | 31 | 0.040 |
Why?
|
11-beta-Hydroxysteroid Dehydrogenase Type 2 | 1 | 2019 | 5 | 0.040 |
Why?
|
Receptors, Glucocorticoid | 1 | 2019 | 12 | 0.040 |
Why?
|
Proto-Oncogene Proteins | 2 | 2001 | 411 | 0.040 |
Why?
|
Immunoblotting | 2 | 2015 | 254 | 0.040 |
Why?
|
Models, Molecular | 1 | 2021 | 546 | 0.040 |
Why?
|
Genes, cdc | 1 | 1999 | 5 | 0.040 |
Why?
|
Corticosterone | 1 | 2019 | 51 | 0.040 |
Why?
|
Reproducibility of Results | 3 | 2011 | 2077 | 0.040 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 2 | 1997 | 272 | 0.040 |
Why?
|
Ubiquitination | 1 | 2019 | 85 | 0.040 |
Why?
|
Proteolysis | 1 | 2019 | 97 | 0.040 |
Why?
|
Minichromosome Maintenance Complex Component 3 | 1 | 1998 | 1 | 0.040 |
Why?
|
Antioxidants | 1 | 2001 | 304 | 0.040 |
Why?
|
Steroids | 1 | 2019 | 84 | 0.040 |
Why?
|
Adult | 5 | 2018 | 21375 | 0.040 |
Why?
|
Liver Cirrhosis | 1 | 2022 | 301 | 0.040 |
Why?
|
Antineoplastic Agents | 2 | 2018 | 1070 | 0.040 |
Why?
|
Reactive Oxygen Species | 1 | 2001 | 499 | 0.040 |
Why?
|
Prostate | 1 | 2019 | 116 | 0.040 |
Why?
|
Osteoblasts | 1 | 2019 | 99 | 0.040 |
Why?
|
Lactation | 1 | 2019 | 110 | 0.040 |
Why?
|
Ectopic Gene Expression | 1 | 2018 | 2 | 0.040 |
Why?
|
Zinc Finger Protein GLI1 | 1 | 2018 | 13 | 0.040 |
Why?
|
Phosphoprotein Phosphatases | 1 | 2018 | 67 | 0.040 |
Why?
|
Pregnancy, Animal | 2 | 2008 | 27 | 0.040 |
Why?
|
Genomic Instability | 1 | 2018 | 41 | 0.040 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 1998 | 69 | 0.040 |
Why?
|
Plasmids | 4 | 2004 | 258 | 0.040 |
Why?
|
Cell Physiological Phenomena | 1 | 1997 | 19 | 0.040 |
Why?
|
Acetylcysteine | 1 | 2001 | 296 | 0.040 |
Why?
|
Models, Theoretical | 2 | 2011 | 384 | 0.040 |
Why?
|
RNA, Small Interfering | 2 | 2009 | 434 | 0.040 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2017 | 48 | 0.040 |
Why?
|
MAP Kinase Kinase Kinases | 1 | 2017 | 34 | 0.040 |
Why?
|
Transcription Factor RelA | 1 | 2017 | 47 | 0.040 |
Why?
|
Middle Aged | 4 | 2021 | 21119 | 0.040 |
Why?
|
Phosphorus Radioisotopes | 1 | 1997 | 29 | 0.040 |
Why?
|
DNA Probes | 1 | 1997 | 57 | 0.040 |
Why?
|
Models, Structural | 2 | 1994 | 22 | 0.040 |
Why?
|
Resting Phase, Cell Cycle | 1 | 1996 | 11 | 0.040 |
Why?
|
Autoradiography | 1 | 1997 | 94 | 0.040 |
Why?
|
Receptor, Notch3 | 1 | 2016 | 2 | 0.040 |
Why?
|
Genes, Fungal | 1 | 1996 | 23 | 0.040 |
Why?
|
Zinc Finger Protein Gli2 | 1 | 2016 | 5 | 0.040 |
Why?
|
Molecular Weight | 3 | 1991 | 358 | 0.040 |
Why?
|
Transforming Growth Factor alpha | 1 | 2016 | 30 | 0.040 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2016 | 25 | 0.040 |
Why?
|
Gene Amplification | 1 | 2016 | 71 | 0.040 |
Why?
|
Protein Interaction Maps | 1 | 2016 | 30 | 0.040 |
Why?
|
Keratinocytes | 1 | 2016 | 68 | 0.030 |
Why?
|
Survival Analysis | 1 | 2018 | 714 | 0.030 |
Why?
|
Protein Precursors | 1 | 1996 | 105 | 0.030 |
Why?
|
Muscle, Skeletal | 1 | 2019 | 396 | 0.030 |
Why?
|
Pregnancy Complications | 1 | 2019 | 286 | 0.030 |
Why?
|
Mitochondria | 1 | 2001 | 643 | 0.030 |
Why?
|
Sequence Deletion | 1 | 1996 | 89 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-jun | 1 | 2016 | 71 | 0.030 |
Why?
|
Thromboplastin | 1 | 1995 | 21 | 0.030 |
Why?
|
Pancreatic Elastase | 1 | 1995 | 33 | 0.030 |
Why?
|
Urokinase-Type Plasminogen Activator | 1 | 1995 | 26 | 0.030 |
Why?
|
Hyaluronic Acid | 1 | 2017 | 206 | 0.030 |
Why?
|
Molecular Chaperones | 1 | 1996 | 81 | 0.030 |
Why?
|
Aprotinin | 1 | 1995 | 55 | 0.030 |
Why?
|
CCCTC-Binding Factor | 1 | 2015 | 5 | 0.030 |
Why?
|
Neoplasm Staging | 1 | 2018 | 799 | 0.030 |
Why?
|
Saccharomyces cerevisiae | 1 | 1996 | 172 | 0.030 |
Why?
|
Nitric Oxide | 1 | 2017 | 382 | 0.030 |
Why?
|
DNA Primers | 2 | 2007 | 302 | 0.030 |
Why?
|
Macrophage Colony-Stimulating Factor | 1 | 2014 | 26 | 0.030 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2017 | 626 | 0.030 |
Why?
|
MAP Kinase Signaling System | 1 | 2016 | 247 | 0.030 |
Why?
|
Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2014 | 29 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-sis | 1 | 2014 | 25 | 0.030 |
Why?
|
Monocarboxylic Acid Transporters | 1 | 2014 | 15 | 0.030 |
Why?
|
Trypsin | 2 | 1991 | 64 | 0.030 |
Why?
|
Symporters | 1 | 2014 | 27 | 0.030 |
Why?
|
Class Ia Phosphatidylinositol 3-Kinase | 1 | 2014 | 2 | 0.030 |
Why?
|
Platelet-Derived Growth Factor | 1 | 2014 | 45 | 0.030 |
Why?
|
Hamartoma Syndrome, Multiple | 1 | 2014 | 6 | 0.030 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2014 | 66 | 0.030 |
Why?
|
Transcription Factor 7-Like 2 Protein | 1 | 2013 | 6 | 0.030 |
Why?
|
DNA Copy Number Variations | 1 | 2014 | 27 | 0.030 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2014 | 18 | 0.030 |
Why?
|
Cricetulus | 1 | 2014 | 98 | 0.030 |
Why?
|
Muscle Proteins | 1 | 2014 | 94 | 0.030 |
Why?
|
CHO Cells | 1 | 2014 | 161 | 0.030 |
Why?
|
Pituitary Neoplasms | 1 | 2014 | 52 | 0.030 |
Why?
|
MCF-7 Cells | 1 | 2013 | 80 | 0.030 |
Why?
|
In Vitro Techniques | 2 | 1991 | 765 | 0.030 |
Why?
|
Tumor Escape | 1 | 1973 | 37 | 0.030 |
Why?
|
Chorioallantoic Membrane | 1 | 2013 | 3 | 0.030 |
Why?
|
Luciferases | 2 | 2004 | 105 | 0.030 |
Why?
|
Precipitin Tests | 2 | 2004 | 88 | 0.030 |
Why?
|
Markov Chains | 1 | 2013 | 133 | 0.030 |
Why?
|
Intestinal Mucosa | 1 | 2014 | 219 | 0.030 |
Why?
|
Feedback, Physiological | 1 | 2013 | 38 | 0.030 |
Why?
|
Cyclin A | 2 | 2004 | 11 | 0.030 |
Why?
|
Case-Control Studies | 1 | 2017 | 1548 | 0.030 |
Why?
|
Pericytes | 1 | 2014 | 81 | 0.030 |
Why?
|
Brain | 2 | 2020 | 2175 | 0.030 |
Why?
|
Risk Assessment | 1 | 2019 | 2004 | 0.030 |
Why?
|
Tissue Plasminogen Activator | 1 | 1995 | 296 | 0.030 |
Why?
|
Cell Count | 1 | 2013 | 248 | 0.030 |
Why?
|
Wnt Signaling Pathway | 1 | 2013 | 57 | 0.030 |
Why?
|
Cell Separation | 2 | 2004 | 132 | 0.030 |
Why?
|
Stem Cell Niche | 1 | 2012 | 7 | 0.030 |
Why?
|
bcl-X Protein | 2 | 2003 | 36 | 0.030 |
Why?
|
Cell Membrane | 1 | 1994 | 523 | 0.030 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 1 | 2012 | 27 | 0.030 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 1 | 2012 | 29 | 0.030 |
Why?
|
S100 Calcium Binding Protein A7 | 1 | 2011 | 4 | 0.030 |
Why?
|
Immunophenotyping | 1 | 2012 | 110 | 0.030 |
Why?
|
Thymus Gland | 1 | 2012 | 97 | 0.030 |
Why?
|
Chemotaxis | 1 | 2011 | 38 | 0.030 |
Why?
|
Receptor for Advanced Glycation End Products | 1 | 2011 | 19 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2013 | 303 | 0.030 |
Why?
|
COS Cells | 1 | 2011 | 155 | 0.030 |
Why?
|
Alternative Splicing | 2 | 2002 | 93 | 0.030 |
Why?
|
Bromodeoxyuridine | 2 | 2002 | 37 | 0.030 |
Why?
|
Mercaptoethanol | 1 | 1991 | 4 | 0.030 |
Why?
|
Receptors, Immunologic | 1 | 2011 | 72 | 0.030 |
Why?
|
Dithiothreitol | 1 | 1991 | 17 | 0.030 |
Why?
|
Bone Marrow | 2 | 2003 | 168 | 0.030 |
Why?
|
Oligonucleotides | 1 | 1991 | 34 | 0.030 |
Why?
|
Zebrafish | 1 | 2012 | 187 | 0.030 |
Why?
|
Ions | 1 | 1991 | 50 | 0.020 |
Why?
|
Solubility | 1 | 1991 | 134 | 0.020 |
Why?
|
Antigens, CD | 1 | 2012 | 230 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2014 | 627 | 0.020 |
Why?
|
Antibodies, Viral | 1 | 1991 | 110 | 0.020 |
Why?
|
NIMA-Related Kinases | 1 | 2010 | 1 | 0.020 |
Why?
|
Fibrocystic Breast Disease | 1 | 2010 | 7 | 0.020 |
Why?
|
Virus Replication | 1 | 1991 | 104 | 0.020 |
Why?
|
Antigen-Antibody Complex | 1 | 1991 | 175 | 0.020 |
Why?
|
Animals, Newborn | 1 | 2011 | 396 | 0.020 |
Why?
|
Paxillin | 1 | 2009 | 3 | 0.020 |
Why?
|
Zinostatin | 1 | 2009 | 2 | 0.020 |
Why?
|
Checkpoint Kinase 1 | 1 | 2009 | 6 | 0.020 |
Why?
|
Focal Adhesion Protein-Tyrosine Kinases | 1 | 2009 | 27 | 0.020 |
Why?
|
Bone Marrow Cells | 2 | 2001 | 217 | 0.020 |
Why?
|
Etoposide | 1 | 2009 | 64 | 0.020 |
Why?
|
Whole-Body Irradiation | 1 | 2009 | 52 | 0.020 |
Why?
|
Acetylation | 1 | 2009 | 94 | 0.020 |
Why?
|
Mice, Inbred C3H | 1 | 2009 | 134 | 0.020 |
Why?
|
Angiogenesis Inhibitors | 1 | 2010 | 64 | 0.020 |
Why?
|
Sirtuin 1 | 1 | 2009 | 47 | 0.020 |
Why?
|
Embryo Transfer | 1 | 2009 | 18 | 0.020 |
Why?
|
Chimera | 1 | 2009 | 33 | 0.020 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2009 | 88 | 0.020 |
Why?
|
Membrane Glycoproteins | 1 | 2012 | 370 | 0.020 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2009 | 82 | 0.020 |
Why?
|
G2 Phase | 2 | 2001 | 26 | 0.020 |
Why?
|
Arabidopsis Proteins | 1 | 2009 | 13 | 0.020 |
Why?
|
Fetal Death | 1 | 2009 | 49 | 0.020 |
Why?
|
Arabidopsis | 1 | 2009 | 20 | 0.020 |
Why?
|
Neuroglia | 1 | 2009 | 136 | 0.020 |
Why?
|
Risk Factors | 1 | 2019 | 5719 | 0.020 |
Why?
|
Homozygote | 1 | 2009 | 119 | 0.020 |
Why?
|
Cyclooxygenase 2 | 1 | 2009 | 160 | 0.020 |
Why?
|
Edema | 1 | 2009 | 66 | 0.020 |
Why?
|
Dinoprostone | 1 | 2009 | 110 | 0.020 |
Why?
|
Fetal Diseases | 1 | 2009 | 64 | 0.020 |
Why?
|
Blood Vessels | 1 | 2009 | 102 | 0.020 |
Why?
|
Mice, Inbred Strains | 2 | 2002 | 181 | 0.020 |
Why?
|
Doxorubicin | 1 | 2009 | 231 | 0.020 |
Why?
|
Vimentin | 1 | 2008 | 47 | 0.020 |
Why?
|
Camptothecin | 1 | 2008 | 39 | 0.020 |
Why?
|
Enterocytes | 1 | 2007 | 7 | 0.020 |
Why?
|
K562 Cells | 1 | 2007 | 44 | 0.020 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 1 | 2008 | 93 | 0.020 |
Why?
|
Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2007 | 32 | 0.020 |
Why?
|
Transgenes | 1 | 2007 | 92 | 0.020 |
Why?
|
Telencephalon | 1 | 2007 | 6 | 0.020 |
Why?
|
Cytokines | 1 | 2011 | 866 | 0.020 |
Why?
|
Adolescent | 2 | 2001 | 8903 | 0.020 |
Why?
|
Hemorrhage | 1 | 2009 | 328 | 0.020 |
Why?
|
Treatment Outcome | 2 | 2013 | 7028 | 0.020 |
Why?
|
Gene Rearrangement | 1 | 2006 | 19 | 0.020 |
Why?
|
Aging | 1 | 2013 | 911 | 0.020 |
Why?
|
Ribs | 1 | 2006 | 25 | 0.020 |
Why?
|
Interneurons | 1 | 2007 | 70 | 0.020 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2006 | 33 | 0.020 |
Why?
|
Surface Properties | 1 | 2007 | 363 | 0.020 |
Why?
|
Rats | 3 | 2000 | 5300 | 0.020 |
Why?
|
User-Computer Interface | 1 | 2007 | 230 | 0.020 |
Why?
|
Imaging, Three-Dimensional | 1 | 2007 | 333 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2003 | 3256 | 0.020 |
Why?
|
Inhibitor of Differentiation Protein 2 | 1 | 2004 | 3 | 0.020 |
Why?
|
Erythroblasts | 1 | 2004 | 4 | 0.020 |
Why?
|
U937 Cells | 1 | 2004 | 61 | 0.020 |
Why?
|
Deoxyribonucleases, Type II Site-Specific | 1 | 2004 | 8 | 0.020 |
Why?
|
Leukemia, Experimental | 1 | 2004 | 14 | 0.020 |
Why?
|
Retroviridae | 1 | 2004 | 29 | 0.020 |
Why?
|
Genome, Human | 1 | 2004 | 62 | 0.020 |
Why?
|
Bone Morphogenetic Protein 3 | 1 | 2004 | 2 | 0.020 |
Why?
|
Growth Differentiation Factor 10 | 1 | 2004 | 2 | 0.020 |
Why?
|
Inhibitor of Apoptosis Proteins | 1 | 2004 | 40 | 0.020 |
Why?
|
Blotting, Northern | 1 | 2004 | 189 | 0.020 |
Why?
|
Tumor Protein p73 | 1 | 2004 | 4 | 0.020 |
Why?
|
Cyclin A2 | 1 | 2004 | 3 | 0.020 |
Why?
|
Cyclin B | 1 | 2004 | 4 | 0.020 |
Why?
|
Cyclin B1 | 1 | 2004 | 7 | 0.020 |
Why?
|
Genes, Reporter | 1 | 2004 | 191 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-rel | 1 | 2003 | 3 | 0.020 |
Why?
|
Eye Abnormalities | 1 | 2004 | 15 | 0.020 |
Why?
|
Aged | 2 | 2001 | 14842 | 0.020 |
Why?
|
In Situ Nick-End Labeling | 1 | 2004 | 160 | 0.010 |
Why?
|
Sulfites | 1 | 2003 | 7 | 0.010 |
Why?
|
Protein Sorting Signals | 1 | 2003 | 11 | 0.010 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 2003 | 95 | 0.010 |
Why?
|
Immunoenzyme Techniques | 1 | 2003 | 196 | 0.010 |
Why?
|
Syndrome | 1 | 2003 | 255 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2007 | 617 | 0.010 |
Why?
|
Tissue Distribution | 1 | 2003 | 282 | 0.010 |
Why?
|
Muridae | 1 | 2002 | 9 | 0.010 |
Why?
|
Thyroid Gland | 1 | 2003 | 67 | 0.010 |
Why?
|
Transcription Initiation Site | 1 | 2002 | 11 | 0.010 |
Why?
|
Crosses, Genetic | 1 | 2002 | 60 | 0.010 |
Why?
|
Introns | 1 | 2002 | 68 | 0.010 |
Why?
|
Testis | 1 | 2002 | 37 | 0.010 |
Why?
|
Genes | 1 | 2002 | 86 | 0.010 |
Why?
|
Thymidine | 1 | 2002 | 32 | 0.010 |
Why?
|
Exons | 1 | 2002 | 122 | 0.010 |
Why?
|
Cell Fractionation | 1 | 2002 | 34 | 0.010 |
Why?
|
Genetic Linkage | 1 | 2002 | 90 | 0.010 |
Why?
|
Base Pair Mismatch | 1 | 2001 | 12 | 0.010 |
Why?
|
Phylogeny | 1 | 2003 | 196 | 0.010 |
Why?
|
Anemia, Refractory, with Excess of Blasts | 1 | 2001 | 3 | 0.010 |
Why?
|
Hemagglutinins | 1 | 2001 | 3 | 0.010 |
Why?
|
Reticulocytes | 1 | 2001 | 7 | 0.010 |
Why?
|
Lactams, Macrocyclic | 1 | 2001 | 7 | 0.010 |
Why?
|
Thrombopoietin | 1 | 2001 | 15 | 0.010 |
Why?
|
Quinones | 1 | 2001 | 13 | 0.010 |
Why?
|
Benzoquinones | 1 | 2001 | 13 | 0.010 |
Why?
|
Reed-Sternberg Cells | 1 | 2001 | 1 | 0.010 |
Why?
|
Genes, Viral | 2 | 1991 | 44 | 0.010 |
Why?
|
Cytoplasm | 1 | 2001 | 155 | 0.010 |
Why?
|
Chromosome Deletion | 2 | 1991 | 41 | 0.010 |
Why?
|
DNA, Recombinant | 1 | 2001 | 25 | 0.010 |
Why?
|
Adenocarcinoma, Follicular | 1 | 2001 | 13 | 0.010 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2001 | 24 | 0.010 |
Why?
|
Carcinoma, Papillary | 1 | 2001 | 35 | 0.010 |
Why?
|
Antibodies | 1 | 2002 | 241 | 0.010 |
Why?
|
Ganglia, Spinal | 1 | 2000 | 29 | 0.010 |
Why?
|
Cisplatin | 1 | 2001 | 192 | 0.010 |
Why?
|
Laminin | 1 | 2000 | 62 | 0.010 |
Why?
|
Tetrahydrofolate Dehydrogenase | 1 | 2000 | 9 | 0.010 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2000 | 144 | 0.010 |
Why?
|
Cattle | 1 | 2001 | 475 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2003 | 444 | 0.010 |
Why?
|
Survival Rate | 1 | 2003 | 1055 | 0.010 |
Why?
|
Thyroid Neoplasms | 1 | 2001 | 68 | 0.010 |
Why?
|
Acute Disease | 1 | 2001 | 658 | 0.010 |
Why?
|
Interleukin-6 | 1 | 2001 | 330 | 0.010 |
Why?
|
Lymph Nodes | 1 | 2001 | 258 | 0.010 |
Why?
|
Fluorescent Dyes | 1 | 2000 | 191 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-raf | 1 | 1999 | 20 | 0.010 |
Why?
|
Half-Life | 1 | 1999 | 96 | 0.010 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1999 | 107 | 0.010 |
Why?
|
Kinetics | 1 | 2000 | 1047 | 0.010 |
Why?
|
Flavonoids | 1 | 1999 | 109 | 0.010 |
Why?
|
Ubiquitins | 1 | 1998 | 22 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 1998 | 24 | 0.010 |
Why?
|
Peptide Hydrolases | 1 | 1998 | 82 | 0.010 |
Why?
|
Oligopeptides | 1 | 1998 | 152 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2010 | 7264 | 0.010 |
Why?
|
Polyribosomes | 1 | 1996 | 24 | 0.010 |
Why?
|
Gene Transfer Techniques | 1 | 1996 | 173 | 0.010 |
Why?
|
Pepsin A | 1 | 1994 | 8 | 0.010 |
Why?
|
Capsid | 1 | 1994 | 8 | 0.010 |
Why?
|
Sialic Acids | 1 | 1994 | 27 | 0.010 |
Why?
|
Protein Structure, Secondary | 1 | 1994 | 136 | 0.010 |
Why?
|
Immunologic Deficiency Syndromes | 1 | 1973 | 13 | 0.010 |
Why?
|
Mice, Inbred NZB | 1 | 1973 | 37 | 0.010 |
Why?
|
Remission, Spontaneous | 1 | 1973 | 25 | 0.010 |
Why?
|
Models, Immunological | 1 | 1973 | 25 | 0.010 |
Why?
|
Immunocompromised Host | 1 | 1973 | 55 | 0.010 |
Why?
|
Lymphoproliferative Disorders | 1 | 1973 | 37 | 0.010 |
Why?
|
Epitopes | 1 | 1973 | 146 | 0.010 |
Why?
|
Antigens, Neoplasm | 1 | 1973 | 132 | 0.010 |
Why?
|
Immune Tolerance | 1 | 1973 | 114 | 0.010 |
Why?
|
Autoimmunity | 1 | 1973 | 118 | 0.010 |
Why?
|
Centrifugation, Density Gradient | 1 | 1991 | 36 | 0.010 |
Why?
|
Chromatography, Gel | 1 | 1991 | 79 | 0.010 |
Why?
|
Mutagenesis | 1 | 1991 | 60 | 0.010 |
Why?
|
Chromatography, Ion Exchange | 1 | 1991 | 73 | 0.010 |
Why?
|
Chymotrypsin | 1 | 1991 | 11 | 0.010 |
Why?
|
Oligonucleotide Probes | 1 | 1990 | 35 | 0.010 |
Why?
|
Mutagenesis, Site-Directed | 1 | 1990 | 204 | 0.010 |
Why?
|
Peptide Fragments | 1 | 1991 | 483 | 0.010 |
Why?
|